Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-07-08

Clinical Trial Update: Safety, Pharmacokinetics and Efficacy of ARQ-151 Cream in Adults With Mild to Moderate Chronic Plaque Psoriasis [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for ARQ-151 cream in adults with mild to moderate chronic plaque psoriasis reports safety, pharmacokinetics, and preliminary efficacy re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ARQ-151 cream (ARQ-151)

Snippet

Sponsor: Arcutis Biotherapeutics, Inc. | Conditions: Psoriasis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-07-08